Dr Vi Khanh Truong

Dr. Vi Khanh Truong is presently a Lecturer in Medical Biotechnology and the Deputy Director of the Biomedical Nanoengineering Laboratory at Flinders University. Prior to this, he held prestigious positions as an RMIT VC Fellow and Fulbright Scholar. Khanh received his Ph.D. in Nanobiotechnology in 2012 from Swinburne.

As an emerging leader in antimicrobial technology, both nationally and internationally, Khanh has made significant contributions to the development of innovative methods for protecting medical devices and surfaces from bacterial colonization. His research follows a "PREVENT-DETECT-TREAT" approach, encompassing a comprehensive strategy to address microbial challenges. Many of his research outcomes have been translated into practical applications, such as antimicrobial products developed by Global Orthopedics, later acquired by Corin Group, and ANISOP Holdings. Collaborating with BlueScope, he contributed to the development of antimicrobial coolroom panels, and with Allegra Orthopedics, he has assisted in developing new antimicrobial bioceramic coatings. He has also co-developed non-medical products such as BASF Divine® Agri and Divine® Integrate soil-wetting agents.

His research has been published in high-impact journals such as Nature Materials, Nature Communications, Advanced Materials, ACS Nano, and PNAS, among others. With over 110 publications and more than 8,000 citations (averaging over 60 citations per paper), his H-index is an impressive 42. In his current work at the Biomedical Nanoengineering Laboratory, Dr. Truong continues to investigate the interactions between microbial cellular structures and nanomaterials, aiming to understand "antimicrobial resistance" and develop "next-generation antimicrobial strategies" in line with his "PREVENT-DETECT-TREAT" approach.